DashboardAll companies
Run this on your own research
Healthcare · Diagnostics & Research

Quest Diagnostics Inc.

DGXNYSE$241.89−$1.39 (−0.57%)Market closed

Price Chart

Daily

Key facts

Market Cap
$26.85B
P/E
27.1x
P/B
3.74x
ROE
14.2%

Quest Diagnostics Inc.

Healthcare · Diagnostics & Research · FY 2025

Quest Diagnostics Inc. is a leading healthcare company specializing in diagnostic information services, with a significant presence in the global diagnostics and research sector. The company provides laboratory testing services that are crucial for medical decision-making, serving physicians, hospitals, and patients. Quest Diagnostics processes one of the largest databases of de-identified clinical lab results worldwide, enabling it to deliver actionable diagnostic insights that support disease detection, treatment management, and overall healthcare quality. The company operates at scale, reportedly serving one in three adult Americans and partnering with over half of U.S. physicians and hospitals. Its offerings encompass a broad range of tests, including routine blood work, advanced genetic screenings, and specialized clinical testing. Quest Diagnostics plays a vital role in the healthcare ecosystem by empowering individuals and organizations with timely, reliable data that informs clinical practice and public health decisions. The company’s extensive reach, data-driven approach, and commitment to innovation reinforce its status as a foundational asset within the healthcare and diagnostic services market.

CEO
Mr. James E. Davis
Employees
55,000

Company Statistics

Valuation

P/E
27.1x
P/B
3.74x
P/S
2.43x
EV/EBITDA
15.3x
P/FCF
19.8x

Margins

Gross
33.2%
EBITDA
19.6%
Operating
14.1%
Pre-Tax
11.9%
Net
9.5%

Returns

ROA
11.3%
ROE
14.2%
ROIC
9.9%

Growth (CAGR)

Rev 3Yr
3.7%
Rev 5Yr
3.2%
Op Inc 3Yr
2.9%
Net Inc 3Yr
1.0%

Financial Health

Cash & Cash Equivalents
$420.0M
Net Debt
$8.52B
Debt/Equity
122.7%
Interest Cov
—

Profile

Revenue
$11.04B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Quest Diagnostics Inc. (DGX) Stock Forecast 2026 $241.89 — Price, Financials & Analyst Targets | AlphaLenz